SCHEMBL25906960

SCHEMBL25906960

CC(C)c1ccc(CCCCCC(C)c2ccc(N(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHKA P35790 4/20 0.43
CHKB Q9Y259 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CALM1 P0DP23 1/20 0.36
SIGMAR1 Q99720 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PYCR1 P32322 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
IDO1 P14902 1/20 0.34
HTR2A P28223 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
UCHL3 P15374 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13955431 0.80 ALDH1A1 (0.48) ALDH1A1MAPK1CYP3A4TSHRTDP1
SCHEMBL21730035 0.79 GAA (0.43) ALDH1A1CYP3A4TSHRMEN1KMT2A
SCHEMBL15144852 0.74 AOC3 (0.44) ALDH1A1MAPK1CYP3A4TSHRTDP1
SCHEMBL346292 0.74 ALDH1A1 (0.61) ALDH1A1MAPK1CYP3A4TSHRTDP1
SCHEMBL2679725 0.74 ESR1 (0.58) ALDH1A1CYP3A4CALM1SIGMAR1
SCHEMBL19146968 0.73 SIGMAR1 (0.50) SIGMAR1PYCR1IDO1HTR2A
SCHEMBL22930079 0.72 ESR1 (0.43) CHKAALDH1A1MAPK1CYP3A4TSHR
Hydrochloric Acid SCHEMBL2861214 0.72 ALDH1A1 (0.58) ALDH1A1MAPK1CYP3A4TSHRTDP1
SCHEMBL6310153 0.72 ALDH1A1 (0.64) CHKACHKBALDH1A1MAPK1CYP3A4
SCHEMBL3359190 0.72 PPARG (0.44) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234950-A1 CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234950-A1 CRBN LIGANDS AND USES THEREOF CRBN, CRKL, ERBB3 CHKA 1169/4885CHKB 973/4885ALDH1A1 4145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.